Statements and Press Releases

Clinical Trial of Human Hookworm Vaccine Begins at Children’s National Medical Center

Submitted by Sabin on Wed, 2012-06-13 00:00

Read more about Clinical Trial of Human Hookworm Vaccine Begins at Children’s National Medical Center

Regional Approach Needed for NTD Control in Conflict-Ridden Middle Eastern Countries

Submitted by Sabin on Tue, 2012-02-28 00:00

WASHINGTON, D.C.—February 28, 2012—Today, the open-access journal PLoS Neglected Tropical Diseas

Read more about Regional Approach Needed for NTD Control in Conflict-Ridden Middle Eastern Countries

Candidate for First Human Hookworm Vaccine Enters Phase 1 Clinical Trial in Brazil

Submitted by Sabin on Thu, 2012-01-19 00:00

Read more about Candidate for First Human Hookworm Vaccine Enters Phase 1 Clinical Trial in Brazil

Major Funding Announced to Continue the Development of a Vaccine for Leading Disease Affecting Global Poor

Submitted by Sabin on Wed, 2011-06-22 00:00

June 22, 2011

Read more about Major Funding Announced to Continue the Development of a Vaccine for Leading Disease Affecting Global Poor

Pages

© 2019 • Sabin Vaccine Institute • 2175 K Street, NW, Suite 400 • Washington, DC 20037 • +1 202 842 5025